{"id":"NCT01624662","sponsor":"Optinose US Inc.","briefTitle":"Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device","officialTitle":"A 16-Week Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (Bid) Using a Novel Bi-directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-week, Open-label Extension Phase to Assess Safety","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10-30","primaryCompletion":"2015-05-11","completion":"2015-07-03","firstPosted":"2012-06-21","resultsPosted":"2018-12-05","lastUpdate":"2018-12-05"},"enrollment":323,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Bilateral Nasal Polyposis"],"interventions":[{"type":"DRUG","name":"Fluticasone propionate","otherNames":["OPN-375"]}],"arms":[{"label":"OPN-375 100 mcg","type":"ACTIVE_COMPARATOR"},{"label":"OPN-375 200 mcg","type":"ACTIVE_COMPARATOR"},{"label":"OPN-375 400 mcg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study was to compare the efficacy of intranasal administration of 100, 200, and 400 μg twice daily (bid) of fluticasone propionate, delivered by the Optinose device, with matching placebo in subjects with bilateral nasal polyposis and nasal congestion.","primaryOutcome":{"measure":"Change in 7-day Average Instantaneous Morning Diary Congestion/Obstruction Symptoms","timeFrame":"Baseline, Week 4 of the double-blind treatment phase","effectByArm":[{"arm":"Placebo","deltaMin":-0.24,"sd":0.07},{"arm":"OPN-375 100 mcg","deltaMin":-0.59,"sd":0.07},{"arm":"OPN-375 200 mcg","deltaMin":-0.68,"sd":0.07},{"arm":"OPN-375 400 mcg","deltaMin":-0.62,"sd":0.07}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":30},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["35437059","34753535","29928924"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":79},"commonTop":["Epistaxis (identified by investigator on routine nasal endoscopy)","Epistaxis (spontaneously reported by subject)","Nasal septum ulceration","URTI","Nasal mucosal disorder"]}}